| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Crizotinib | FAERS: 2 | US FAERS | |
| 2 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 3 | Zoledronic Acid | FAERS: 2 | US FAERS | |
| 4 | Bortezomib | FAERS: 1 | US FAERS | |
| 5 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 6 | Nitrofurantoin | FAERS: 1 | US FAERS | |
| 7 | Teriparatide | FAERS: 1 | US FAERS | |
| 8 | baricitinib | FAERS: 1 | US FAERS | |
| 9 | gemcitabine | FAERS: 1 | US FAERS | |
| 10 | Carbamazepine | OFFSIDES | ||
| 11 | Flunitrazepam | OFFSIDES | ||
| 12 | Salmeterol Xinafoate | OFFSIDES | ||
| 13 | Temozolomide | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.